Retrospective Study
Copyright ©The Author(s) 2021.
World J Hepatol. May 27, 2021; 13(5): 584-594
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.584
Figure 3
Figure 3 Disease-free survival. Median disease-free survival was 52 d. There was no statistical difference between angiosarcoma and undifferentiated sarcoma groups.